Patent · US Active

Method for producing soluble FcR as Fc-fusion with inert immunoglobulin Fc-region and uses thereof

US10011644B2 · kind B2 · utility

9Cited by

1References

3Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Petra Rueger · Penzberg, DE
Tilman Schlothauer
Stefan Seeber · Penzberg, DE

Key dates

Filing date	Feb 2, 2015
Grant date	Jul 3, 2018
Priority date	—
Expiry date	Apr 14, 2036

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/70535
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Herein is a fusion polypeptide with the formula R1-FC-R2, wherein R1 denotes a first Fc-receptor, R2 denotes a second Fc-receptor, and FC denotes a heavy chain Fc-region polypeptide, wherein R1 or R2 or both are present, wherein FC does not substantially bind to R1 and/or R2 and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.